Nervgen Pharma Corporation (NGEN)
TSXV
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Cash from Operating Activities | -1.04M | -8.09M | -6.31M | -8.27M | -17.78M | -11.3M |
Cash from Investing Activities | -127k | N/A | -3k | -44k | -21k | -139k |
Cash from Financing Activities | 3.59M | 9.84M | 7.85M | 19.61M | 22.64M | 766k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.